Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie Perry

Showing results (391-400 of 422) with videos related to

Pageof 43
Sort By:
Acta Neuropathologica|May 21, 2014
Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutationsLeanne de Kock, Nelly Sabbaghian, François Plourde, et al.
Neuro-Oncology|December 23, 2024
VGLL fusions define a new class of intraparenchymal central nervous system schwannomaSimone Schmid, Kanish Mirchia, Anna Tietze, et al.
Neuro-Oncology|November 19, 2024
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responsesCalixto-Hope G Lucas, Nadeem N Al-Adli, Jacob S Young, et al.
Brain Pathology (Zurich, Switzerland)|December 15, 2019
Clinicopathologic and molecular features of intracranial desmoplastic small round cell tumorsJulieann C Lee, Javier E Villanueva-Meyer, Sean P Ferris, et al.
Brain Pathology (Zurich, Switzerland)|November 25, 2021
Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomasEmily A Sloan, Rohit Gupta, Christian Koelsche, et al.
Brain Pathology (Zurich, Switzerland)|October 15, 2019
Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic featuresCalixto-Hope G Lucas, Javier E Villanueva-Meyer, Nicholas Whipple, et al.
Brain Pathology (Zurich, Switzerland)|November 3, 2020
Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasmsEmily A Sloan, Jason Chiang, Javier E Villanueva-Meyer, et al.
Acta Neuropathologica|December 15, 2020
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1Philipp Sievers, Martin Sill, Christina Blume, et al.
Pituitary|December 14, 2019
Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolutionSylvia L Asa, Sofia Asioli, Suheyla Bozkurt, et al.
Acta Neuropathologica|March 12, 2020
Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic featuresEmily A Sloan, Stephanie Hilz, Rohit Gupta, et al.
Pageof 43

Showing results (391-400 of 422) with videos related to

Sort By:
Pageof 43
Acta Neuropathologica|May 21, 2014
Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutationsLeanne de Kock, Nelly Sabbaghian, François Plourde, et al.
Neuro-Oncology|December 23, 2024
VGLL fusions define a new class of intraparenchymal central nervous system schwannomaSimone Schmid, Kanish Mirchia, Anna Tietze, et al.
Neuro-Oncology|November 19, 2024
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responsesCalixto-Hope G Lucas, Nadeem N Al-Adli, Jacob S Young, et al.
Brain Pathology (Zurich, Switzerland)|December 15, 2019
Clinicopathologic and molecular features of intracranial desmoplastic small round cell tumorsJulieann C Lee, Javier E Villanueva-Meyer, Sean P Ferris, et al.
Brain Pathology (Zurich, Switzerland)|November 25, 2021
Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomasEmily A Sloan, Rohit Gupta, Christian Koelsche, et al.
Brain Pathology (Zurich, Switzerland)|October 15, 2019
Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic featuresCalixto-Hope G Lucas, Javier E Villanueva-Meyer, Nicholas Whipple, et al.
Brain Pathology (Zurich, Switzerland)|November 3, 2020
Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasmsEmily A Sloan, Jason Chiang, Javier E Villanueva-Meyer, et al.
Acta Neuropathologica|December 15, 2020
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1Philipp Sievers, Martin Sill, Christina Blume, et al.
Pituitary|December 14, 2019
Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolutionSylvia L Asa, Sofia Asioli, Suheyla Bozkurt, et al.
Acta Neuropathologica|March 12, 2020
Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic featuresEmily A Sloan, Stephanie Hilz, Rohit Gupta, et al.
Pageof 43